The beneficial effect of solTNF neutralization in reducing intestinal inflammation in obesity is particularly important because intestinal immune alterations are a recognized contributor to metabolic syndrome comorbidities such as glucose and insulin impairment and CNS neurodegenerative processes [49, 50]. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.